1. Home
  2. PRSO vs PLUR Comparison

PRSO vs PLUR Comparison

Compare PRSO & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.30

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$1.09

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
PLUR
Founded
2008
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.5M
IPO Year
2000
2026

Fundamental Metrics

Financial Performance
Metric
PRSO
PLUR
Price
$0.30
$1.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 11.7M
62.2K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.23
31.46
EPS
★ N/A
N/A
Revenue
★ $14,573,000.00
$1,016,000.00
Revenue This Year
N/A
$902.46
Revenue Next Year
$191.73
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 5.99
N/A
52 Week Low
$0.28
$0.85
52 Week High
$2.10
$4.12

Technical Indicators

Market Signals
Indicator
PRSO
PLUR
Relative Strength Index (RSI) 36.98 40.32
Support Level N/A $0.88
Resistance Level $0.46 $1.85
Average True Range (ATR) 0.04 0.12
MACD -0.01 -0.02
Stochastic Oscillator 10.38 0.00

Price Performance

Historical Comparison
PRSO
PLUR

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: